Company / PP&E per Share
Syndax Pharmaceuticals Inc PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#178 of 191
Health Care
What the data says
Among 191 Health Care companies, Syndax Pharmaceuticals Inc is in the bottom 7% for pp&e per share. PP&E per Share returned to growth in FY2025 after 6 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -21.5%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +79.7%
- 5-Year CAGR
- -21.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #178 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.00 | -67.7% |
| FY2022 | $0.00 | -93.7% |
| FY2021 | $0.01 | -17.9% |
| FY2020 | $0.01 | -37.5% |
| FY2019 | $0.01 | -26.0% |
| FY2018 | $0.02 | +4.3% |
| FY2017 | $0.01 | -99.5% |
| FY2016 | $3.04 | +136.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026